gvtcx

Framework for the supply of Radiopharmaceuticals and Related Consumables - 2023

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£100,000,000
Statuscomplete
Category (CPV) 09344000 +2 more
Deadline7 Jul 2023
Procedureopen
OCIDocds-h6vhtk-03cfab

Awards (4)

This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is £100,000,000.

SupplierValueDateStatus
Alliance Medical Radiopharmacy Limited shared · · active
Curium Pharma UK Ltd shared · · active
GE Healthcare Limited shared · · active
Xiel Limited shared · · active

description

HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
26 May 2023 Contract notice (F02) Earlier regulations 015037-2023
12 Dec 2023 Contract award notice (F03) Earlier regulations 036473-2023

more from HealthTrust Europe LLP (HTE) acting on behalf of Mid and South Essex NHS Foundation ("Authority").

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.